1. Home
  2. MBRX vs NVVE Comparison

MBRX vs NVVE Comparison

Compare MBRX & NVVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MBRX
  • NVVE
  • Stock Information
  • Founded
  • MBRX 2015
  • NVVE 1996
  • Country
  • MBRX United States
  • NVVE United States
  • Employees
  • MBRX N/A
  • NVVE N/A
  • Industry
  • MBRX Biotechnology: Pharmaceutical Preparations
  • NVVE Oil Refining/Marketing
  • Sector
  • MBRX Health Care
  • NVVE Energy
  • Exchange
  • MBRX Nasdaq
  • NVVE Nasdaq
  • Market Cap
  • MBRX 4.4M
  • NVVE 3.7M
  • IPO Year
  • MBRX 2016
  • NVVE N/A
  • Fundamental
  • Price
  • MBRX $0.81
  • NVVE $1.06
  • Analyst Decision
  • MBRX Strong Buy
  • NVVE
  • Analyst Count
  • MBRX 3
  • NVVE 0
  • Target Price
  • MBRX $17.33
  • NVVE N/A
  • AVG Volume (30 Days)
  • MBRX 651.2K
  • NVVE 178.6K
  • Earning Date
  • MBRX 05-09-2025
  • NVVE 03-31-2025
  • Dividend Yield
  • MBRX N/A
  • NVVE N/A
  • EPS Growth
  • MBRX N/A
  • NVVE N/A
  • EPS
  • MBRX N/A
  • NVVE N/A
  • Revenue
  • MBRX N/A
  • NVVE $5,286,229.00
  • Revenue This Year
  • MBRX N/A
  • NVVE $200.61
  • Revenue Next Year
  • MBRX N/A
  • NVVE $109.43
  • P/E Ratio
  • MBRX N/A
  • NVVE N/A
  • Revenue Growth
  • MBRX N/A
  • NVVE N/A
  • 52 Week Low
  • MBRX $0.40
  • NVVE $1.00
  • 52 Week High
  • MBRX $5.91
  • NVVE $17.30
  • Technical
  • Relative Strength Index (RSI)
  • MBRX 33.73
  • NVVE 27.69
  • Support Level
  • MBRX $0.92
  • NVVE $1.53
  • Resistance Level
  • MBRX $1.04
  • NVVE $1.16
  • Average True Range (ATR)
  • MBRX 0.10
  • NVVE 0.14
  • MACD
  • MBRX -0.02
  • NVVE -0.01
  • Stochastic Oscillator
  • MBRX 6.22
  • NVVE 8.00

About MBRX Moleculin Biotech Inc.

Moleculin Biotech Inc is a clinical stage pharmaceutical company focused on the development of a broad portfolio of drug candidates for the treatment of resistant tumors and viruses. The company's Annamycin program is a next-generation anthracycline designed to avoid multidrug resistance mechanisms with little to no cardiotoxicity.

About NVVE Nuvve Holding Corp.

Nuvve Holding Corp is accelerating the electrification of transportation through its proprietary vehicle-to-grid (V2G) technology. It helps to support the integration of renewable energy sources, including solar and wind. Its Grid Integrated Vehicle (GIV) platform is refueling the next generation of electric vehicle fleets through bidirectional charging solutions. It has a geographic presence in the United States, the United Kingdom, and Denmark, of which it generates the majority of its revenue in the United States.

Share on Social Networks: